Connection

CHRIS AMOS to Carrier Proteins

This is a "connection" page, showing publications CHRIS AMOS has written about Carrier Proteins.
Connection Strength

0.772
  1. Expression of a 65 kDa oncofetal protein in human prostatic carcinoma. Oncol Rep. 2003 Sep-Oct; 10(5):1387-92.
    View in: PubMed
    Score: 0.141
  2. A PGC1? genetic variant associated with nevus count and melanoma mortality. Int J Cancer. 2017 09 01; 141(5):1066-1067.
    View in: PubMed
    Score: 0.092
  3. Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis. 2017 05 01; 38(5):541-551.
    View in: PubMed
    Score: 0.091
  4. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet. 2016 09 01; 25(17):3863-3876.
    View in: PubMed
    Score: 0.086
  5. PGC-1 coactivators regulate MITF and the tanning response. Mol Cell. 2013 Jan 10; 49(1):145-57.
    View in: PubMed
    Score: 0.067
  6. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J Clin Gastroenterol. 2009 May-Jun; 43(5):444-7.
    View in: PubMed
    Score: 0.052
  7. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004 May; 36(5):471-5.
    View in: PubMed
    Score: 0.037
  8. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol. 2004 Feb; 99(2):306-15.
    View in: PubMed
    Score: 0.036
  9. Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers. Am J Hum Genet. 2003 Nov; 73(5):1157-61.
    View in: PubMed
    Score: 0.036
  10. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res. 2001 Feb 15; 61(4):1269-71.
    View in: PubMed
    Score: 0.030
  11. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 2000 Jan 15; 60(2):249-52.
    View in: PubMed
    Score: 0.027
  12. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8.
    View in: PubMed
    Score: 0.024
  13. Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model. Cancer Lett. 2009 May 18; 277(2):149-54.
    View in: PubMed
    Score: 0.013
  14. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res. 2005 Dec 01; 11(23):8281-7.
    View in: PubMed
    Score: 0.010
  15. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control. 2005 Aug; 16(6):749-53.
    View in: PubMed
    Score: 0.010
  16. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res. 2004 Sep 01; 10(17):5845-9.
    View in: PubMed
    Score: 0.009
  17. Design and methodology of a study of psychosocial aspects of genetic testing for hereditary colorectal cancer. Ann N Y Acad Sci. 1997 Dec 29; 833:190-4.
    View in: PubMed
    Score: 0.006
  18. Linkage between the APOB gene and serum ApoB levels in a large pedigree from the Bogalusa Heart Study. Genet Epidemiol. 1994; 11(1):29-40.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.